intranasal GDNF gene therapy approach for treating Parkinson's disease
Author(s) -
Aly
Publication year - 2017
Language(s) - Uncategorized
Resource type - Dissertations/theses
DOI - 10.17760/d20260243
Subject(s) - glial cell line derived neurotrophic factor , neuroprotection , neurotrophic factors , dopaminergic , dopamine , medicine , genetic enhancement , nasal administration , parkinson's disease , gene delivery , neuroscience , pharmacology , disease , biology , gene , biochemistry , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom